[{"address1": "88 Sidney Street", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 649 8600", "website": "https://www.agios.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 486, "companyOfficers": [{"maxAge": 1, "name": "Mr. Brian M. Goff M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1458975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James William Burns", "age": 46, "title": "Corporate Secretary & Chief Legal Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 1019942, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sarah  Gheuens M.D., Ph.D.", "age": 44, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 1247567, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lewis Clayton Cantley Ph.D.", "age": 75, "title": "Founder", "yearBorn": 1949, "fiscalYear": 2023, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.", "age": 78, "title": "Founder", "yearBorn": 1946, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Craig B. Thompson M.D.", "age": 71, "title": "Founder", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shin-San  Su Ph.D.", "age": 68, "title": "Founder", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. T. J. Washburn", "age": 42, "title": "VP, Controller & Principal Accounting Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. M. Taylor", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Vickers", "title": "Vice President of Sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 3, "compensationRisk": 4, "shareHolderRightsRisk": 7, "overallRisk": 5, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 33.3, "open": 32.93, "dayLow": 32.86, "dayHigh": 34.68, "regularMarketPreviousClose": 33.3, "regularMarketOpen": 32.93, "regularMarketDayLow": 32.86, "regularMarketDayHigh": 34.68, "beta": 0.876, "trailingPE": 2.853952, "forwardPE": -5.7300563, "volume": 667366, "regularMarketVolume": 667366, "averageVolume": 853989, "averageVolume10days": 679120, "averageDailyVolume10Day": 679120, "bid": 24.56, "ask": 42.08, "bidSize": 200, "askSize": 200, "marketCap": 1903379840, "fiftyTwoWeekLow": 26.19, "fiftyTwoWeekHigh": 62.58, "priceToSalesTrailing12Months": 52.15025, "fiftyDayAverage": 37.779, "twoHundredDayAverage": 42.86515, "currency": "USD", "enterpriseValue": 1066656640, "profitMargins": 18.45923, "floatShares": 50734037, "sharesOutstanding": 57296200, "sharesShort": 5027013, "sharesShortPriorMonth": 5526130, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0881, "heldPercentInsiders": 0.01502, "heldPercentInstitutions": 1.08507, "shortRatio": 6.36, "shortPercentOfFloat": 0.08939999, "impliedSharesOutstanding": 57296200, "bookValue": 26.96, "priceToBook": 1.232196, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 673724992, "trailingEps": 11.64, "forwardEps": -6.08, "enterpriseToRevenue": 29.225, "enterpriseToEbitda": -2.539, "52WeekChange": 0.2287823, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "AGIO", "underlyingSymbol": "AGIO", "shortName": "Agios Pharmaceuticals, Inc.", "longName": "Agios Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1374672600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "52f076ec-0de6-382e-b01b-3ddfa165dcb4", "messageBoardId": "finmb_46539787", "gmtOffSetMilliseconds": -18000000, "currentPrice": 33.22, "targetHighPrice": 74.0, "targetLowPrice": 45.0, "targetMeanPrice": 55.14286, "targetMedianPrice": 54.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 893710016, "totalCashPerShare": 15.598, "ebitda": -420084000, "totalDebt": 56988000, "quickRatio": 11.063, "currentRatio": 11.898, "totalRevenue": 36498000, "debtToEquity": 3.698, "revenuePerShare": 0.642, "returnOnAssets": -0.20466, "returnOnEquity": 0.5729, "grossProfits": -268952992, "freeCashflow": -222825632, "operatingCashflow": -389840992, "revenueGrowth": 0.511, "operatingMargins": -11.653029, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]